Shape-sensing robotic bronchoscopy to diagnose peripheral lung nodules
Official title: Shape-sensing Robotic-assisted Bronchoscopy (ssRAB) for Diagnosis of Peripheral Pulmonary Nodules: A Prospective Cohort Study in Korea (the ULSAN-ION Study)
Run by Ulsan University Hospital · NCT07057648 · Data updated 2026-11-12
This tests a shape-sensing robotic bronchoscopy to see if it can get tissue samples from adults in Korea with peripheral lung nodules.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Ulsan University Hospital Academic / other |
| Locations | 1 site (Ulsan) |
| Status | Recruiting |
| Started | July 9, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07057648 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19 or older with solid or part-solid peripheral pulmonary nodules who need histologic diagnosis and are fit for bronchoscopy under sedation or general anesthesia (ECOG 0–2) are ideal candidates.
✕Probably not a fit
Patients with pure ground-glass nodules, significant bleeding risk, severe cardiopulmonary dysfunction preventing deep sedation, pregnancy, or life expectancy under six months are unlikely to benefit from this procedure.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center observational cohort in which shape-sensing robotic-assisted bronchoscopy (ssRAB) replaces conventional bronchoscopy for patients needing tissue diagnosis of peripheral pulmonary nodules. Planning uses thin-section chest CT to create a 3D navigation map, and the ssRAB system uses shape-sensing fiber optics to guide and stabilize the bronchoscopic catheter to the target. Procedures are performed under sedation or general anesthesia with tissue sampling and safety monitoring, and patients are followed for adverse events and diagnostic outcomes for six months. The main focus is on diagnostic yield and safety of ssRAB in a Korean clinical setting.
Why it matters
Potential benefit: If successful, ssRAB could increase the chance of getting a definitive tissue diagnosis from bronchoscopy and reduce the need for riskier procedures.
How similar studies have gone: International studies of the same ssRAB system have reported diagnostic yields around 87–90% with favorable safety profiles, suggesting promising results outside Korea.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 19 years or older * Solid or part-solid peripheral pulmonary nodules confirmed on chest computed tomography (CT) * Patients requiring histological diagnosis as determined by the treating physician * Patients eligible for bronchoscopy procedure * Ability to provide written informed consent * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or equivalent functional status allowing procedure under sedation or general anesthesia Exclusion Criteria: * Pure ground glass opacity nodules * Bleeding tendency defined as platelet count less than 50,000/μL or International Normalized Ratio (INR) greater than 1.5 * Severe cardiopulmonary dysfunction precluding deep sedation or general anesthesia * Pregnant or breastfeeding women * Life expectancy less than 6 months as assessed by the treating physician * Inability or unwillingness to provide informed consent * Absolute contraindication to bronchoscopy including: * Severe hypoxemia (oxygen saturation \<90% on room air) * Severe pulmonary hypertension * Recent myocardial infarction (within 6 weeks) * Unstable angina * Malignant arrhythmias * Participation in another interventional clinical trial that may interfere with study procedures or outcomes
Where it's running
-
Ulsan University Hospital
Ulsan, South Korea Recruiting
Study contacts
- Principal investigator: Ganghee Chae, MD, PhD — Ulsan University Hospital
- Study coordinator: Ganghee Chae, MD, PhD
- Email: ganghee@uuh.ulsan.kr
- Phone: +82-52-250-8705
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-driven autonomous registration for robotic bronchoscopy localization
This trial will test whether an AI system can automatically register and help guide robotic bronchoscopy for adults who need pulmonary nodule localization.
-
AI-assisted longitudinal CT to guide indeterminate lung nodules
This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.
-
3D airway mapping guides double-lumen tube sizing for thoracic surgery
This study tests whether 3D airway reconstruction helps choose the best double-lumen breathing tube size for adults undergoing thoracic surgery.
-
Multi-patient CT-derived Digital Twin Training to Shorten the Bronchoscopy Learning Curve
This trial tests if training with digital twins from multiple CT scans helps novices learn bronchoscopy faster than standard anatomically uniform simulation training.
-
Intraoperative 3D Longitude-Latitude-Depth Localization vs CT-Guided Lung Localization for Small Peripheral Nodules
This study tests whether intraoperative 3D longitude–latitude–depth localization can identify 0.8–2 cm peripheral lung nodules as reliably as the standard preoperative CT-guided localization in adults undergoing VATS surgery.
-
Pre-Emptive Parecoxib for Pain During CT-Guided Lung Nodule Localization
This study tests whether giving parecoxib sodium before a CT-guided needle localization of lung nodules can reduce pain for patients undergoing VATS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.